Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)
Clinical trial NCT04700488 · SUSPENDED
Trial details
- NCT number
- NCT04700488
- Sponsor
- Cedars-Sinai Medical Center
- Status
- SUSPENDED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2026-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.